Home/Filings/4/0000950170-23-063925
4//SEC Filing

Awad Antoine 4

Accession 0000950170-23-063925

CIK 0001527599other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 7:22 PM ET

Size

37.5 KB

Accession

0000950170-23-063925

Insider Transaction Report

Form 4
Period: 2023-11-10
Awad Antoine
Chief Operating Officer
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-11-103,6660 total
    Exercise: $130.35Exp: 2029-02-28Common Stock (3,666 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-11-106,6660 total
    Exercise: $9.30Exp: 2033-03-16Common Stock (6,666 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-11-104,6660 total
    Exercise: $27.75Exp: 2030-07-14Common Stock (4,666 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-11-1011,0310 total
    Exercise: $29.25Exp: 2032-02-04Common Stock (11,031 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-11-1016,6660 total
    Exercise: $9.30Exp: 2033-03-16Common Stock (16,666 underlying)
  • Award

    Stock Option (right to buy)

    2023-11-10+3,6663,666 total
    Exercise: $1.85Exp: 2029-02-28Common Stock (3,666 underlying)
  • Award

    Stock Option (right to buy)

    2023-11-10+666666 total
    Exercise: $1.85Exp: 2029-03-05Common Stock (666 underlying)
  • Award

    Stock Option (right to buy)

    2023-11-10+6,6666,666 total
    Exercise: $1.85Exp: 2033-03-16Common Stock (6,666 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-11-106660 total
    Exercise: $128.85Exp: 2029-03-05Common Stock (666 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-11-104,6660 total
    Exercise: $25.50Exp: 2030-03-10Common Stock (4,666 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-11-104,6660 total
    Exercise: $52.50Exp: 2031-03-10Common Stock (4,666 underlying)
  • Award

    Stock Option (right to buy)

    2023-11-10+4,6664,666 total
    Exercise: $1.85Exp: 2030-03-10Common Stock (4,666 underlying)
  • Award

    Stock Option (right to buy)

    2023-11-10+4,6664,666 total
    Exercise: $1.85Exp: 2031-03-10Common Stock (4,666 underlying)
  • Award

    Stock Option (right to buy)

    2023-11-10+16,66616,666 total
    Exercise: $1.85Exp: 2033-03-16Common Stock (16,666 underlying)
  • Award

    Stock Option (right to buy)

    2023-11-10+4,6664,666 total
    Exercise: $1.85Exp: 2030-07-14Common Stock (4,666 underlying)
  • Award

    Stock Option (right to buy)

    2023-11-10+11,03111,031 total
    Exercise: $1.85Exp: 2032-02-04Common Stock (11,031 underlying)
Footnotes (8)
  • [F1]In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements.
  • [F2]The shares subject to this option are fully vested as of the date hereof.
  • [F3]These performance-based stock options, granted on March 16, 2023, vest when the achievement of certain clinical and regulatory development milestones are met.
  • [F4]The shares subject to this option vest in approximately equal monthly installments beginning on April 1, 2020 through April 1, 2024.
  • [F5]The shares subject to this option vest in approximately equal monthly installments beginning on July 1, 2020 through July 1, 2024.
  • [F6]The shares subject to this option vest in approximately equal monthly installments beginning on April 1, 2021 through April 1, 2025.
  • [F7]The shares subject to this option vest in approximately equal monthly installments beginning on February 4, 2022 through February 4, 2026.
  • [F8]The shares subject to this option vest in approximately equal monthly installments beginning on April 1, 2023 through April 1, 2027.

Documents

1 file

Issuer

SYNLOGIC, INC.

CIK 0001527599

Entity typeother

Related Parties

1
  • filerCIK 0001820122

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 7:22 PM ET
Size
37.5 KB